Lejeune, Julien <br/><br/>
Evidence for linkage disequilibrium between Fcgamma RIIIa-V158F and Fcgamma RIIa-H131R polymorphisms in white patients, and for an Fcgamma RIIIa-restricted influence on the response to therapeutic antibodies.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Nov 2008 
 - 5489-91; author reply 5491-2 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2008.19.4118  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Humans<br/>Linkage Disequilibrium<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Polymorphism, Genetic<br/>Receptors, IgG--genetics<br/>Rituximab<br/>White People--genetics